NCT00931528 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Beginning ≤ 7 days after the start of radiotherapy, patients receive oral tadalafil 5mg once daily for 24 weeks.
- id
- FG000
- title
- Tadalafil
- description
- Beginning ≤ 7 days after the start of radiotherapy, patients receive oral placebo once daily for 24 weeks.
- id
- FG001
- title
- Placebo
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 9
- group Id
- FG001
- num Subjects
- 12
- type
- Protocol Violation
- reasons
- group Id
- FG000
- num Subjects
- 4
- group Id
- FG001
- num Subjects
- 12
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 6
- group Id
- FG001
- num Subjects
- 13
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 22
- group Id
- FG001
- num Subjects
- 23
- type
- Assessment outside of Time Frame
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 121
- group Id
- FG001
- num Subjects
- 121
- type
- STARTED
- achievements
- comment
- Subjects with data available for the primary analysis are considered to have completed the study.
- group Id
- FG000
- num Subjects
- 80
- comment
- Subjects with data available for the primary analysis are considered to have completed the study.
- group Id
- FG001
- num Subjects
- 61
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 41
- group Id
- FG001
- num Subjects
- 60
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- Beginning ≤ 7 days after the start of radiotherapy, patients receive oral tadalafil 5mg once daily for 24 weeks.
- id
- FG000
- title
- Tadalafil
- description
- Beginning ≤ 7 days after the start of radiotherapy, patients receive oral placebo once daily for 24 weeks.
- id
- FG001
- title
- Placebo
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 9
- group Id
- FG001
- num Subjects
- 12
- type
- Protocol Violation
- reasons
- group Id
- FG000
- num Subjects
- 4
- group Id
- FG001
- num Subjects
- 12
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 6
- group Id
- FG001
- num Subjects
- 13
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 22
- group Id
- FG001
- num Subjects
- 23
- type
- Assessment outside of Time Frame
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 121
- group Id
- FG001
- num Subjects
- 121
- type
- STARTED
- achievements
- comment
- Subjects with data available for the primary analysis are considered to have completed the study.
- group Id
- FG000
- num Subjects
- 80
- comment
- Subjects with data available for the primary analysis are considered to have completed the study.
- group Id
- FG001
- num Subjects
- 61
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 41
- group Id
- FG001
- num Subjects
- 60
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle